Case studies
Our case studies showcase our work within all phases of drug development. Each case clearly states the challenges and customer needs, and the services and solutions we provided.
Crovalimab dose justification based on Phase 3 data in paroxysomal nocturnal hemoglobinurea patients
Assessment of the probability of a drug asset to exceed the target efficacy value in major depression disorder trials using literature data of ketamine and esketamine
